CARL Carlsmed, Inc. - Common Stock
$15,13
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$8–$17
76% of range
Analystenbewertung
BUY
11 analysts
Kursziel
$19
+27% upside
P/E (TTM)
-7.3
ROE
-375.2%
Nettogewinnmarge
-58.7%
CARL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$15.13
Marktkapitalisierung
$411M
P/E (TTM)
-7.3
EPS (TTM)
$-2.12
Umsatz (TTM)
$51M
Dividendenrendite
—
ROE
-375.2%
Verschuldungsgrad
—
52W-Spanne
$9 – $17
CARL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$51M
2024-12-31
→
2025-12-31
EPS
$-2.12
2024-12-31
→
2025-12-31
Freier Cashflow
$-30M
2025-12-31
→
2025-12-31
Margen
-58.7%
2025-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CARL
Peer-Median
P/E (TTM)
-7.3
27.5
P/S (TTM) (K/V (TTM))
8.1
6.8
P/B (K/B)
4.2
3.7
Price / FCF (Kurs / FCF)
-13.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CARL
Peer-Median
Gross Margin (Bruttogewinnmarge)
75.3%
75.9%
Operating Margin (Betriebsgewinnmarge)
-60.5%
—
Net Profit Margin (Nettogewinnmarge)
-58.7%
-46.8%
ROA
-32.6%
-31.4%
ROE
-375.2%
-59.1%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CARL
Peer-Median
Current Ratio (Liquiditätsgrad)
8.9
4.6
Quick Ratio
8.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CARL
Peer-Median
Revenue YoY (Umsatz YoY)
85.9%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CARL
Peer-Median
CARL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
11 Analysten
- Starker Kauf 4 36,4%
- Kauf 6 54,5%
- Halten 1 9,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-17
Median
$18.00
Mittelwert
$19.20
← Unter allen Zielen
$15.13
Tief
$17.00
Hoch
$23.00
Median-Ziel
$18.00
+19,0%
Mittelwert-Ziel
$19.20
+26,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.07%
Nächster Bericht
Aug 26, 2026
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.39 | $-0.42 | 0.03% |
| 31. März 2026 | $-0.32 | $-0.40 | 0.08% |
| 31. Dezember 2025 | $-0.32 | $-0.43 | 0.11% |
| 30. September 2025 | $-0.40 | $-0.46 | 0.06% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| MOBI | — | — | — | — | — | — |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| TMCI | — | -2.6 | 1.6% | -27.7% | -63.8% | 79.8% |
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $51M | $27M | |
| Cost of Revenue | $12M | $7M | |
| Gross Profit | $38M | $20M | |
| R&D Expense | $17M | $14M | |
| SG&A Expense | $17M | $8M | |
| Operating Expenses | $69M | $44M | |
| Operating Income | $-31M | $-24M | |
| Interest Expense | $1M | $1M | |
| Interest Income | $3M | $1M | |
| Other Non-op | $940.0K | $-135.0K | |
| Income Tax | $0 | $0 | |
| Net Income | $-30M | $-24M | |
| EPS (Basic) | $-2.12 | $-6.11 | |
| EPS (Diluted) | $-2.12 | $-6.11 | |
| Shares (Basic) | 14,221,991 | 4,066,395 | |
| Shares (Diluted) | 14,221,991 | 4,066,395 | |
| EBITDA | $-30M | · |
Bilanz 25
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $86M | $40M | |
| Short-term Investments | $24M | $0 | |
| Receivables | $11M | $7M | |
| Inventory | $2M | $995.0K | |
| Prepaid Expense | $4M | $1M | |
| Current Assets | $127M | $49M | |
| PP&E (Net) | $1M | $260.0K | |
| PP&E (Gross) | $2M | $659.0K | |
| Accum. Depreciation | $526.0K | $399.0K | |
| Other Non-current Assets | $134.0K | $569.0K | |
| Total Assets | $130M | $52M | |
| Accounts Payable | $4M | $2M | |
| Accrued Liabilities | $3M | $3M | |
| Current Liabilities | $14M | $9M | |
| Capital Leases | $1M | $1M | |
| Other Non-current Liabilities | $309.0K | $222.0K | |
| Total Liabilities | $31M | $26M | |
| Long-term Debt | $15M | $15M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $200M | $541.0K | |
| Retained Earnings | $-101M | $-71M | |
| AOCI | $0 | · | |
| Stockholders' Equity | $99M | $-71M | |
| Liabilities + Equity | $130M | $52M | |
| Shares Outstanding | 26,604,505 | 4,139,219 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $281.0K | $145.0K | |
| Stock-based Comp | $2M | $253.0K | |
| Other Non-cash | $-2M | · | |
| Operating Cash Flow | $-29M | $-25M | |
| CapEx | $642.0K | $180.0K | |
| Investing Cash Flow | $-25M | $-180.0K | |
| Financing Cash Flow | $100M | $58M | |
| Free Cash Flow | $-30M | · |
Rentabilität 6
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 75.3% | · | |
| Operating Margin | -60.5% | · | |
| Net Margin | -58.7% | · | |
| EBITDA Margin | -60.0% | · | |
| ROA | -32.6% | · | |
| ROE | -375.2% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 8.9 | · | |
| Quick Ratio | 8.5 | · | |
| Interest Coverage | -21.4 | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.6 | · | |
| Inventory Turnover | 8.8 | · | |
| Receivables Turnover | 5.6 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 85.9% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $51M | · | |
| Net Income TTM | $-30M | · | |
| Market Cap | $329M | · | |
| P/E | -5.8 | · | |
| P/S | 6.5 | · | |
| P/B | 3.3 | · | |
| P / Tangible Book | 3.3 | · | |
| P / Cash Flow | -11.3 | · | |
| P / FCF | -11.1 | · | |
| Earnings Yield | -17.2% | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $16M | $15M | $13M | $12M | $10M | $9M | $7M | |
| Cost of Revenue | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Gross Profit | $15M | $12M | $12M | $10M | $9M | $8M | $7M | $5M | |
| R&D Expense | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $4M | |
| SG&A Expense | $8M | $6M | $5M | $5M | $3M | $3M | $2M | $2M | |
| Operating Expenses | $26M | $22M | $21M | $19M | $15M | $13M | $12M | $13M | |
| Operating Income | $-11M | $-9M | $-9M | $-9M | $-7M | $-6M | $-5M | $-8M | |
| Interest Expense | $313.0K | $311.0K | $330.0K | $380.0K | $363.0K | $357.0K | $378.0K | $402.0K | |
| Interest Income | $839.0K | $891.0K | $1M | $954.0K | $336.0K | $380.0K | $410.0K | $394.0K | |
| Other Non-op | $526.0K | $580.0K | $705.0K | $509.0K | $-264.0K | $-10.0K | $-23.0K | $-36.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-11M | $-9M | $-9M | $-9M | $-7M | $-6M | $-5M | $-8M | |
| EPS (Basic) | $-0.39 | $-0.32 | $0.03 | $-0.40 | $-1.47 | $-1.47 | $-1.14 | $-2.06 | |
| EPS (Diluted) | $-0.39 | $-0.32 | $0.03 | $-0.40 | $-1.47 | $-1.47 | $-1.14 | $-2.06 | |
| Shares (Basic) | 27,190,765 | 26,835,841 | 4,170,368 | 21,081,330 | 4,589,717 | 4,299,492 | 20,185 | 4,088,553 | |
| Shares (Diluted) | 27,190,765 | 26,835,841 | 4,170,368 | 21,081,330 | 4,589,717 | 4,299,492 | 20,185 | 4,088,553 | |
| EBITDA | $-11M | $-9M | · | $-9M | $-7M | · | · | · |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $73M | $86M | $115M | $33M | · | $40M | · | |
| Short-term Investments | $24M | $24M | $24M | · | · | · | $0 | · | |
| Receivables | $14M | $12M | $11M | $11M | $10M | · | $7M | · | |
| Inventory | $2M | $2M | $2M | $1M | $1M | · | $995.0K | · | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $2M | · | $1M | · | |
| Current Assets | $110M | $115M | $127M | $131M | $46M | · | $49M | · | |
| PP&E (Net) | $2M | $2M | $1M | $1M | $972.0K | · | $260.0K | · | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $1M | · | $659.0K | · | |
| Accum. Depreciation | $726.0K | $624.0K | $526.0K | $428.0K | $380.0K | · | $399.0K | · | |
| Other Non-current Assets | $253.0K | $103.0K | $134.0K | $225.0K | $4M | · | $569.0K | · | |
| Total Assets | $118M | $119M | $130M | $135M | $53M | · | $52M | · | |
| Accounts Payable | $4M | $3M | $4M | $3M | $3M | · | $2M | · | |
| Accrued Liabilities | $4M | $3M | $3M | $3M | $3M | · | $3M | · | |
| Current Liabilities | $12M | $10M | $14M | $11M | $9M | · | $9M | · | |
| Capital Leases | $6M | $1M | $1M | $2M | $2M | · | $1M | · | |
| Other Non-current Liabilities | $345.0K | $327.0K | $309.0K | $290.0K | $267.0K | · | $222.0K | · | |
| Total Liabilities | $34M | $27M | $31M | $28M | $28M | · | $26M | · | |
| Long-term Debt | $15M | $15M | $15M | $15M | $15M | · | $15M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | · | $0 | · | |
| Paid-in Capital | $204M | $202M | $200M | $199M | $593.0K | · | $541.0K | · | |
| Retained Earnings | $-120M | $-110M | $-101M | $-92M | $-84M | · | $-71M | · | |
| AOCI | $-17.0K | · | · | · | · | · | · | · | |
| Stockholders' Equity | $84M | $92M | $99M | $107M | $-83M | · | $-71M | · | |
| Liabilities + Equity | $118M | $119M | $130M | $135M | $53M | · | $52M | · | |
| Shares Outstanding | 27,225,759 | 27,181,501 | 26,604,505 | 26,584,077 | 4,603,756 | · | 4,139,219 | · |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $130.0K | $99.0K | $98.0K | $82.0K | $61.0K | $40.0K | $37.0K | $33.0K | |
| Stock-based Comp | $2M | $2M | $790.0K | $704.0K | $258.0K | $175.0K | $100.0K | $66.0K | |
| Other Non-cash | · | $-6M | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-13M | $-5M | $-8M | $-7M | $-8M | $-4M | $-8M | |
| CapEx | $121.0K | $79.0K | $73.0K | $159.0K | $327.0K | $83.0K | $61.0K | $52.0K | |
| Investing Cash Flow | $-20M | $-206.0K | $-24M | $-343.0K | $-672.0K | $-238.0K | $-61.0K | $-52.0K | |
| Financing Cash Flow | $243.0K | $436.0K | $-29.0K | $91M | $-2M | $12M | $-51.0K | $14M | |
| Free Cash Flow | · | $-13M | · | · | · | · | · | · |
Rentabilität 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.8% | 77.1% | · | 75.9% | 73.4% | · | · | · | |
| Operating Margin | -58.3% | -57.6% | · | -69.1% | -53.8% | · | · | · | |
| Net Margin | -55.5% | -54.0% | · | -65.2% | -56.0% | · | · | · | |
| EBITDA Margin | -58.3% | -56.9% | · | -69.1% | -53.8% | · | · | · | |
| ROA | -12.3% | -14.6% | · | -12.6% | -25.4% | · | · | · | |
| ROE | -1792.0% | -18.9% | · | -16.0% | 16.3% | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.8 | 11.9 | · | 12.0 | 4.9 | · | · | · | |
| Quick Ratio | 6.8 | 11.2 | · | 11.6 | 4.6 | · | · | · | |
| Interest Coverage | -35.3 | -29.8 | · | -23.8 | -17.9 | · | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | 0.2 | 0.5 | · | · | · | |
| Inventory Turnover | 2.6 | 3.6 | · | 4.7 | 6.0 | · | · | · | |
| Receivables Turnover | 1.6 | 2.6 | · | 2.3 | 2.5 | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $60M | $51M | · | · | · | · | · | · | |
| Net Income TTM | $-34M | $-30M | · | $-29M | $-27M | · | · | · | |
| Market Cap | $283M | $246M | · | $356M | · | · | · | · | |
| P/E | -4.0 | -2.5 | · | · | · | · | · | · | |
| P/S | 4.7 | 4.8 | · | · | · | · | · | · | |
| P/B | 3.4 | 2.7 | · | 3.3 | · | · | · | · | |
| P / Tangible Book | 3.4 | 2.7 | · | 3.3 | · | · | · | · | |
| P / Cash Flow | · | -18.9 | · | · | · | · | · | · | |
| P / FCF | · | -18.8 | · | · | · | · | · | · | |
| Earnings Yield | -24.9% | -40.4% | · | · | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Umsatz | $51M | $27M |
| Bruttogewinnmarge % | 75.3% | — |
| Betriebsgewinnmarge % | -60.5% | — |
| Nettoergebnis | $-30M | $-24M |
| Verwässerte EPS | $-2.12 | $-6.11 |
Bilanz
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Liquiditätsgrad | 8.9 | — |
| Quick Ratio | 8.5 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Freier Cashflow | $-30M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 76 Einreicher · $50.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 26 (+9 vs. Vorquartal) | 13 (+3 vs. Vorquartal) | 28 (+14 vs. Vorquartal) | 11 (-5 vs. Vorquartal) | -766K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $11.108.441 | 1.227.452 | 21,86% | Aktien |
| Parkman Healthcare Partners LLC | $6.200.161 | 597.318 | 12,20% | Aktien |
| KCM Capital Inc | $4.567.200 | 440.000 | 8,99% | Aktien |
| Pier Capital, LLC | $3.878.767 | 373.677 | 7,63% | Aktien |
| VANGUARD GROUP INC | $3.852.101 | 311.911 | 7,58% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.071.515 | 295.907 | 6,04% | Aktien |
| Palumbo Wealth Management LLC | $2.774.554 | 267.298 | 5,46% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.477.986 | 238.727 | 4,88% | Aktien |
| Schonfeld Strategic Advisors LLC | $2.333.464 | 224.804 | 4,59% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.841.449 | 177.330 | 3,62% | Aktien |
| STATE STREET CORP | $1.381.402 | 133.083 | 2,72% | Aktien |
| CITADEL ADVISORS LLC | $1.055.916 | 101.726 | 2,08% | Aktien |
| GOLDMAN SACHS GROUP INC | $655.248 | 63.126 | 1,29% | Aktien |
| D. E. Shaw & Co., Inc. | $627.357 | 60.439 | 1,23% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $591.120 | 56.948 | 1,16% | Aktien |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $536.521 | 51.688 | 1,06% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $518.253 | 49.928 | 1,02% | Aktien |
| JANE STREET GROUP, LLC | $436.323 | 42.035 | 0,86% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $414.691 | 39.951 | 0,82% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $259.500 | 25.000 | 0,51% | Aktien |
| Boston Partners | $232.250 | 22.375 | 0,46% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $186.923 | 18.008 | 0,37% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $181.256 | 17.462 | 0,36% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $179.325 | 17.276 | 0,35% | Aktien |
| ALPINE WOODS CAPITAL INVESTORS, LLC | $161.326 | 15.542 | 0,32% | Aktien |
| Centiva Capital, LP | $154.569 | 14.891 | 0,30% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $145.735 | 14.040 | 0,29% | Aktien |
| Board of Trustees of The Leland Stanford Junior University | $129.916 | 12.516 | 0,26% | Aktien |
| Trexquant Investment LP | $114.190 | 11.001 | 0,22% | Aktien |
| BANK OF AMERICA CORP /DE/ | $107.910 | 10.396 | 0,21% | Aktien |
| DEUTSCHE BANK AG\ | $105.668 | 10.180 | 0,21% | Aktien |
| WELLS FARGO & COMPANY/MN | $76.532 | 7.373 | 0,15% | Aktien |
| RHUMBLINE ADVISERS | $60.074 | 5.788 | 0,12% | Aktien |
| Bank of New York Mellon Corp | $59.488 | 5.731 | 0,12% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $40.409 | 3.893 | 0,08% | Aktien |
| CITIGROUP INC | $40.368 | 3.889 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $37.129 | 3.577 | 0,07% | Aktien |
| MORGAN STANLEY | $24.134 | 2.325 | 0,05% | Aktien |
| UBS Group AG | $20.947 | 2.018 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $18.684 | 1.800 | 0,04% | Aktien |
| BlackRock, Inc. | $15.975 | 1.539 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $13.058 | 1.258 | 0,03% | Aktien |
| ARMSTRONG ADVISORY GROUP, INC | $12.809 | 1.234 | 0,03% | Aktien |
| Tower Research Capital LLC (TRC) | $12.508 | 1.205 | 0,02% | Aktien |
| FMR LLC | $11.989 | 1.155 | 0,02% | Aktien |
| BARCLAYS PLC | $11.740 | 1.131 | 0,02% | Aktien |
| Legal & General Group Plc | $10.655 | 1.024 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $10.525 | 1.014 | 0,02% | Aktien |
| Integrated Wealth Concepts LLC | $10.371 | 999 | 0,02% | Aktien |
| Arax Advisory Partners | $7.775 | 749 | 0,02% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $7.409 | 630 | 0,01% | Aktien |
| MARSHALL WACE, LLP | $7.214 | 695 | 0,01% | Aktien |
| US BANCORP \DE\ | $6.228 | 600 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $5.865 | 565 | 0,01% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.163 | 460 | 0,01% | Aktien |
| ROYAL BANK OF CANADA | $3.000 | 275 | 0,01% | Aktien |
| Allworth Financial LP | $1.869 | 180 | 0,00% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.671 | 161 | 0,00% | Aktien |
| Russell Investments Group, Ltd. | $1.557 | 150 | 0,00% | Aktien |
| Sterling Capital Management LLC | $1.090 | 105 | 0,00% | Aktien |
| Farther Finance Advisors, LLC | $1.005 | 96 | 0,00% | Aktien |
| Jump Financial, LLC | $945 | 91 | 0,00% | Aktien |
| Essential Partners LLC | $706 | 68 | 0,00% | Aktien |
| IFP Advisors, Inc | $550 | 53 | 0,00% | Aktien |
| True Wealth Design, LLC | $540 | 52 | 0,00% | Aktien |
| CWM, LLC | $534 | 59 | 0,00% | Aktien |
| Fortitude Family Office, LLC | $311 | 30 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $289 | 26 | 0,00% | Aktien |
| ROTHSCHILD INVESTMENT LLC | $249 | 24 | 0,00% | Aktien |
| EverSource Wealth Advisors, LLC | $239 | 23 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $208 | 20 | 0,00% | Aktien |
| SJS Investment Consulting Inc. | $198 | 19 | 0,00% | Aktien |
| Janney Montgomery Scott LLC | $135 | 13.025 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $73 | 7 | 0,00% | Aktien |
| Clearstead Advisors, LLC | $53 | 5 | 0,00% | Aktien |
| JPL Wealth Management, LLC | $11 | 1 | 0,00% | Aktien |
Unternehmensinsider 9 Insider · 4 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael Cordonnier | CEO, President | 3. März 2026 M | 1.550.477 | 0 | 1 | $-2.629.493 |
| Leonard M. Greenstein | CFO, Treasurer | 28. Januar 2026 A | 188.346 | 0 | 0 | $0 |
| Niall Casey | Chief IP Officer | 28. Januar 2026 A | 982.562 | 0 | 0 | $0 |
| William Scott Durall | Chief Commercial Officer | 28. Januar 2026 A | 44.977 | 0 | 0 | $0 |
| Kevin Sidow | Direktor | 3. Juni 2026 A | 73.264 | 0 | 0 | $0 |
| Jonathan D Root | Direktor | 3. Juni 2026 A | 497.697 | 0 | 0 | $0 |
| Kevin C Oboyle | Direktor | 3. Juni 2026 A | 31.031 | 0 | 0 | $0 |
| Philip M Young | Direktor | 3. Juni 2026 A | 31.031 | 0 | 0 | $0 |
| Robert Mittendorff II | Direktor | 24. Juli 2025 C | 931.452 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 15 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 28.345 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,00% | 43.368 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,00% | 41.321 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 208.673 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,00% | 381 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,00% | 3.024 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 299 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 306 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 8 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 73.487 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 158.583 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 48.152 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.942 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.297 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 557 SH | 8. August 2026 | Täglich |